These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 36202457

  • 1. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
    Peretto G, Busnardo E, Ferro P, Palmisano A, Vignale D, Esposito A, De Luca G, Campochiaro C, Sartorelli S, De Gaspari M, Rizzo S, Dagna L, Basso C, Gianolli L, Della Bella P, Sala S.
    JACC Cardiovasc Imaging; 2022 Oct; 15(10):1771-1780. PubMed ID: 36202457
    [Abstract] [Full Text] [Related]

  • 2. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, Müller KAL, Castor T, Mahrholdt H, Häntschel M, Hetzel J, Dittmann H, Nikolaou K, Gawaz M, la Fougère C, Krumm P.
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [Abstract] [Full Text] [Related]

  • 3. Positron emission tomography in clinically suspected myocarditis - STREAM study design.
    Ozierański K, Tymińska A, Kobylecka M, Caforio ALP, Šobić-Šaranović D, Ristić AD, Maksimović R, Seferović PM, Marcolongo R, Królicki L, Opolski G, Grabowski M.
    Int J Cardiol; 2021 Jun 01; 332():113-118. PubMed ID: 33657398
    [Abstract] [Full Text] [Related]

  • 4. Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
    Ozawa K, Funabashi N, Daimon M, Takaoka H, Takano H, Uehara M, Kobayashi Y.
    Int J Cardiol; 2013 Nov 05; 169(3):196-200. PubMed ID: 24075573
    [Abstract] [Full Text] [Related]

  • 5. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
    Trivieri MG, Robson PM, Vergani V, LaRocca G, Romero-Daza AM, Abgral R, Devesa A, Azoulay LD, Karakatsanis NA, Parikh A, Panagiota C, Palmisano A, DePalo L, Chang HL, Rothstein JH, Fayad RA, Miller MA, Fuster V, Narula J, Dweck MR, Morgenthau A, Jacobi A, Padilla M, Kovacic JC, Fayad ZA.
    JACC Cardiovasc Imaging; 2024 Apr 05; 17(4):411-424. PubMed ID: 38300202
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB.
    Eur J Nucl Med Mol Imaging; 2016 Feb 05; 43(2):259-269. PubMed ID: 26359191
    [Abstract] [Full Text] [Related]

  • 9. 18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis.
    Omote K, Naya M, Koyanagawa K, Aikawa T, Manabe O, Nagai T, Kamiya K, Kato Y, Komoriyama H, Kuzume M, Tamaki N, Anzai T.
    J Nucl Cardiol; 2020 Dec 05; 27(6):2135-2143. PubMed ID: 30610523
    [Abstract] [Full Text] [Related]

  • 10. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
    Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, Nassenstein K, Schlosser T.
    J Nucl Cardiol; 2018 Jun 05; 25(3):785-794. PubMed ID: 27638745
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R, Patel AR.
    Int J Cardiovasc Imaging; 2021 Apr 05; 37(4):1361-1369. PubMed ID: 33225427
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A, Wicks E, Ashworth M, Stephenson E, Guttmann O, Savvatis K, Sekhri N, Mohiddin SA, Syrris P, Menezes L, Elliott P.
    Int J Cardiol; 2019 Jun 01; 284():99-104. PubMed ID: 30409737
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of fluorine-18 fluoro-2-deoxyglucose positron emission computed tomography in patients with unexplained atrioventricular block.
    Danwade TA, Devidutta S, Shelke AB, Saggu DK, Yalagudri SD, Sridevi C, Reddy NK, Narasimhan C.
    Heart Rhythm; 2018 Feb 01; 15(2):234-239. PubMed ID: 29061522
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z, Habibi M, Okada DR, Smith J, Derakhshan A, Zimmerman SL, Misra S, Gilotra NA, Berger RD, Calkins H, Tandri H, Chrispin J.
    Am J Cardiol; 2020 Nov 01; 134():123-129. PubMed ID: 32950203
    [Abstract] [Full Text] [Related]

  • 20. Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
    Sperry BW, Oldan JD, Hsich EM, Reynolds JP, Tamarappoo BK.
    J Nucl Cardiol; 2015 Aug 01; 22(4):840-4. PubMed ID: 25968627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.